Effect of denosumab on bone turnover markers in critically ill women - A safety and feasibility, randomised, placebo, controlled trial

  • Orford, Neil (Primary Chief Investigator (PCI))
  • Cooper, Jamie (Associate Investigator (AI))
  • Bellomo, Rinaldo (Associate Investigator (AI))
  • Bailey, Michael (Associate Investigator (AI))
  • Kolowicz, Mark (Associate Investigator (AI))
  • Maiden, Mathew (Associate Investigator (AI))
  • Kakho, Nima (Associate Investigator (AI))

Project: Research

Project Description

A prospective, randomised, placebo-controlled, safety and feasibility trial to assess the effects of intravenous denosumab on bone mass in post-menopausal female intensive care patients expected to require greater than 24 hours of mechanical ventilation.
Short titleSkeletal Outcomes Following Intensive Care
AcronymSOFTER
StatusNot started